Trial site
Great Lakes Research Group, Inc.
- 11running trials
- 9closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Obesity11 trials
- Type 2 diabetes6 trials
- Atopic dermatitis (eczema)4 trials
- Osteoarthritis4 trials
- Alopecia areata2 trials
- Obstructive sleep apnoea1 trial
- Psoriasis1 trial
- Type 1 diabetes1 trial
- Vitiligo1 trial
- Phase
- Phase 314 trials
- Phase 24 trials
- Phase 1/21 trial
- Phase 41 trial
- Status
- Completed8 trials
- Active, not recruiting7 trials
- Recruiting3 trials
- Enrolling by invitation1 trial
- Withdrawn1 trial
- Lead sponsor
- Eli Lilly and Company17 trials
- Evommune, Inc.1 trial
- Incyte Corporation1 trial
- Inmagene LLC1 trial
Running trials
Recruiting
Recruiting
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
Active, not recruiting
Enrolling by invitation
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Osteoarthritis2 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Obesity1 recruiting
Closed trials
Completed
Completed
Withdrawn
Completed
Completed
Completed
Completed
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
Completed
Completed
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata
Site data: ClinicalTrials.govUpdated 13 Nov 2026